Lung cancer association appoints CEO
Click Here to Manage Email Alerts
Karen L. Kelly, MD, has been appointed CEO of International Association for the Study of Lung Cancer.
The appointment will take effect this spring.
Kelly, a former member of the association’s board of directors, is recognized for her expertise in lung cancer research.
“The IASLC board is delighted with the appointment of Dr. Karen Kelly as the next IASLC CEO,” Heather A. Wakelee, MD, president of the association’s board of directors, said in a press release. “Dr. Kelly’s longstanding and active membership in the organization, outstanding leadership skills and preeminence as an internationally renowned thoracic oncologist make her the ideal candidate to lead the IASLC as our next CEO.”
Kelly most recently served as professor of medicine and associate director for clinical research at UC Davis Comprehensive Cancer Center. She held the Jennifer Rene Harmon Tegley and Elizabeth Erica Harmon endowed chair in cancer clinical research at UC Davis.
Kelly also has served as chair of SWOG’s lung committee since 2016.
“I am honored to serve the members of the IASLC as their next CEO,” Kelly said in the release. “I am committed to its growth and enhancement. There has never been a more exciting time for our lung cancer community as the whisper of cure becomes an audible reality. Meaningful advances in lung cancer care are rapidly coming [and], coupled with tackling health disparities and access to optimal care, ultimate impact will be achieved.”
Read more about
Click Here to Manage Email Alerts